Concepts (233)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Spinal Fractures | 20 | 2024 | 103 | 5.070 |
Why?
|
| Absorptiometry, Photon | 27 | 2024 | 116 | 5.050 |
Why?
|
| Bone Density | 33 | 2026 | 247 | 5.050 |
Why?
|
| Hypoparathyroidism | 19 | 2026 | 30 | 4.890 |
Why?
|
| Osteoporotic Fractures | 9 | 2024 | 57 | 4.420 |
Why?
|
| Osteoporosis | 15 | 2022 | 134 | 3.920 |
Why?
|
| Parathyroid Hormone | 19 | 2026 | 233 | 3.130 |
Why?
|
| Cancellous Bone | 6 | 2022 | 22 | 2.860 |
Why?
|
| Fractures, Bone | 5 | 2024 | 160 | 1.720 |
Why?
|
| Hormone Replacement Therapy | 9 | 2026 | 104 | 1.630 |
Why?
|
| Calcaneus | 6 | 2013 | 40 | 1.500 |
Why?
|
| Hip Fractures | 3 | 2023 | 54 | 1.470 |
Why?
|
| Lumbar Vertebrae | 11 | 2021 | 376 | 1.350 |
Why?
|
| Vitamin D | 16 | 2026 | 285 | 1.320 |
Why?
|
| Body Composition | 3 | 2022 | 88 | 1.320 |
Why?
|
| Quality of Life | 12 | 2026 | 1895 | 1.300 |
Why?
|
| Femur Neck | 10 | 2024 | 42 | 1.040 |
Why?
|
| Risk Assessment | 10 | 2024 | 2585 | 0.970 |
Why?
|
| Calcium | 16 | 2026 | 1196 | 0.850 |
Why?
|
| Osteoporosis, Postmenopausal | 6 | 2014 | 33 | 0.820 |
Why?
|
| Aged | 37 | 2026 | 21760 | 0.800 |
Why?
|
| Middle Aged | 39 | 2026 | 29442 | 0.780 |
Why?
|
| Diabetes Mellitus | 2 | 2020 | 811 | 0.760 |
Why?
|
| Female | 52 | 2026 | 51570 | 0.760 |
Why?
|
| Electronic Health Records | 2 | 2024 | 442 | 0.760 |
Why?
|
| Diabetes Complications | 2 | 2020 | 176 | 0.720 |
Why?
|
| Densitometry | 4 | 2015 | 23 | 0.700 |
Why?
|
| Humans | 71 | 2026 | 98135 | 0.700 |
Why?
|
| Women's Health | 1 | 2022 | 119 | 0.650 |
Why?
|
| Spine | 3 | 2017 | 148 | 0.640 |
Why?
|
| Nutrition Surveys | 5 | 2022 | 134 | 0.630 |
Why?
|
| Aged, 80 and over | 16 | 2024 | 7387 | 0.630 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2020 | 42 | 0.620 |
Why?
|
| Male | 40 | 2026 | 47109 | 0.610 |
Why?
|
| Wrist Injuries | 1 | 2019 | 14 | 0.610 |
Why?
|
| Humeral Fractures | 1 | 2019 | 30 | 0.590 |
Why?
|
| Glomerular Filtration Rate | 1 | 2020 | 299 | 0.580 |
Why?
|
| Recombinant Proteins | 7 | 2025 | 993 | 0.580 |
Why?
|
| Accelerometry | 1 | 2019 | 49 | 0.560 |
Why?
|
| Femur | 2 | 2017 | 108 | 0.560 |
Why?
|
| Body Fat Distribution | 1 | 2017 | 13 | 0.530 |
Why?
|
| Whole Body Imaging | 1 | 2017 | 40 | 0.520 |
Why?
|
| Adult | 28 | 2026 | 29564 | 0.480 |
Why?
|
| Societies, Medical | 4 | 2015 | 682 | 0.470 |
Why?
|
| Exercise | 1 | 2019 | 380 | 0.450 |
Why?
|
| Tomography, X-Ray Computed | 3 | 2020 | 2668 | 0.430 |
Why?
|
| Patient Reported Outcome Measures | 3 | 2026 | 336 | 0.410 |
Why?
|
| Retrospective Studies | 10 | 2024 | 10962 | 0.400 |
Why?
|
| Bone and Bones | 2 | 2026 | 270 | 0.400 |
Why?
|
| Thoracic Vertebrae | 3 | 2016 | 89 | 0.390 |
Why?
|
| Double-Blind Method | 9 | 2026 | 1783 | 0.380 |
Why?
|
| Cross-Sectional Studies | 6 | 2025 | 2037 | 0.380 |
Why?
|
| Predictive Value of Tests | 6 | 2024 | 1784 | 0.370 |
Why?
|
| Risk Factors | 10 | 2024 | 6232 | 0.360 |
Why?
|
| Vitamin D Deficiency | 3 | 2026 | 119 | 0.350 |
Why?
|
| Glucocorticoids | 5 | 2016 | 370 | 0.320 |
Why?
|
| Diabetes Insipidus | 2 | 2006 | 16 | 0.310 |
Why?
|
| Hip Joint | 3 | 2018 | 58 | 0.310 |
Why?
|
| Patient Selection | 2 | 2014 | 725 | 0.310 |
Why?
|
| Pennsylvania | 2 | 2020 | 108 | 0.310 |
Why?
|
| Heart Transplantation | 1 | 2016 | 873 | 0.300 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 3 | 2007 | 462 | 0.300 |
Why?
|
| Incidence | 4 | 2026 | 1777 | 0.290 |
Why?
|
| Frail Elderly | 1 | 2009 | 96 | 0.270 |
Why?
|
| Chicago | 3 | 2024 | 1513 | 0.270 |
Why?
|
| Vitamins | 2 | 2026 | 93 | 0.270 |
Why?
|
| Treatment Outcome | 11 | 2026 | 9713 | 0.260 |
Why?
|
| Dietary Supplements | 2 | 2026 | 152 | 0.250 |
Why?
|
| Body Mass Index | 3 | 2022 | 850 | 0.250 |
Why?
|
| Calcium, Dietary | 3 | 2022 | 69 | 0.240 |
Why?
|
| Radiography | 4 | 2015 | 763 | 0.240 |
Why?
|
| Prevalence | 4 | 2016 | 1383 | 0.230 |
Why?
|
| Vasopressins | 4 | 1988 | 49 | 0.220 |
Why?
|
| Calcitriol | 3 | 2020 | 173 | 0.210 |
Why?
|
| Proof of Concept Study | 1 | 2024 | 63 | 0.210 |
Why?
|
| Bone Matrix | 1 | 2003 | 20 | 0.200 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2024 | 632 | 0.190 |
Why?
|
| Chronic Disease | 3 | 2026 | 985 | 0.190 |
Why?
|
| Parathyroid Hormone-Related Protein | 1 | 2022 | 11 | 0.190 |
Why?
|
| Age Factors | 3 | 2016 | 1967 | 0.180 |
Why?
|
| Bone Density Conservation Agents | 1 | 2022 | 53 | 0.180 |
Why?
|
| Practice Guidelines as Topic | 3 | 2022 | 1109 | 0.160 |
Why?
|
| Thirst | 3 | 1988 | 19 | 0.150 |
Why?
|
| Registries | 2 | 2025 | 1122 | 0.150 |
Why?
|
| Abdomen | 1 | 2020 | 120 | 0.150 |
Why?
|
| Comorbidity | 2 | 2021 | 1031 | 0.150 |
Why?
|
| Logistic Models | 3 | 2010 | 1275 | 0.150 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2017 | 1307 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 3 | 2006 | 72 | 0.140 |
Why?
|
| Pelvic Bones | 1 | 2019 | 46 | 0.140 |
Why?
|
| Risk | 1 | 2019 | 660 | 0.140 |
Why?
|
| Mexican Americans | 1 | 2018 | 72 | 0.130 |
Why?
|
| Hip | 1 | 2017 | 18 | 0.130 |
Why?
|
| Hypocalcemia | 1 | 2017 | 43 | 0.130 |
Why?
|
| Hyperphosphatemia | 1 | 2017 | 25 | 0.130 |
Why?
|
| United States | 4 | 2020 | 8193 | 0.130 |
Why?
|
| Clinical Trials as Topic | 2 | 2018 | 1131 | 0.130 |
Why?
|
| Osteocalcin | 1 | 2016 | 25 | 0.120 |
Why?
|
| Alkaline Phosphatase | 1 | 2016 | 129 | 0.120 |
Why?
|
| Acetabulum | 1 | 2016 | 22 | 0.120 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2016 | 51 | 0.120 |
Why?
|
| Parathyroidectomy | 1 | 2016 | 87 | 0.120 |
Why?
|
| Sensitivity and Specificity | 6 | 2008 | 1948 | 0.120 |
Why?
|
| Prednisone | 1 | 2016 | 251 | 0.120 |
Why?
|
| Phosphates | 1 | 2016 | 165 | 0.120 |
Why?
|
| Disability Evaluation | 1 | 2016 | 186 | 0.110 |
Why?
|
| Artifacts | 1 | 2017 | 248 | 0.110 |
Why?
|
| Health Status | 1 | 2018 | 385 | 0.110 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 342 | 0.110 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 4026 | 0.110 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 338 | 0.110 |
Why?
|
| Obesity | 1 | 2022 | 1061 | 0.110 |
Why?
|
| Physicians | 1 | 2021 | 685 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 916 | 0.100 |
Why?
|
| Severity of Illness Index | 2 | 2017 | 2013 | 0.100 |
Why?
|
| Surveys and Questionnaires | 4 | 2025 | 3022 | 0.100 |
Why?
|
| Autoimmune Diseases | 1 | 2016 | 259 | 0.100 |
Why?
|
| Guidelines as Topic | 1 | 2013 | 169 | 0.090 |
Why?
|
| Prognosis | 1 | 2020 | 4116 | 0.090 |
Why?
|
| Radiographic Image Enhancement | 2 | 2004 | 449 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2003 | 3618 | 0.080 |
Why?
|
| Cohort Studies | 3 | 2025 | 3213 | 0.080 |
Why?
|
| Homeostasis | 2 | 2016 | 474 | 0.080 |
Why?
|
| Anthropometry | 1 | 2010 | 77 | 0.080 |
Why?
|
| Age Distribution | 1 | 2010 | 208 | 0.080 |
Why?
|
| Body Height | 1 | 2010 | 109 | 0.070 |
Why?
|
| Epidemiologic Methods | 1 | 2009 | 60 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2009 | 38 | 0.070 |
Why?
|
| Adipogenesis | 1 | 2009 | 46 | 0.070 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 1988 | 19 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2009 | 135 | 0.070 |
Why?
|
| Protein Isoforms | 1 | 2009 | 303 | 0.070 |
Why?
|
| Mass Screening | 1 | 2013 | 745 | 0.070 |
Why?
|
| Activities of Daily Living | 1 | 2009 | 214 | 0.070 |
Why?
|
| Illinois | 1 | 2009 | 522 | 0.060 |
Why?
|
| Osteogenesis | 1 | 2009 | 278 | 0.060 |
Why?
|
| Menstrual Cycle | 1 | 1988 | 84 | 0.060 |
Why?
|
| Equipment Failure Analysis | 2 | 2004 | 88 | 0.060 |
Why?
|
| Body Water | 1 | 1987 | 34 | 0.060 |
Why?
|
| Parathyroid Glands | 2 | 2017 | 77 | 0.060 |
Why?
|
| Bone Remodeling | 1 | 2026 | 22 | 0.060 |
Why?
|
| Fractals | 1 | 2006 | 41 | 0.060 |
Why?
|
| Reproducibility of Results | 3 | 2007 | 2787 | 0.060 |
Why?
|
| Antibodies | 1 | 1988 | 349 | 0.060 |
Why?
|
| Estrogens | 2 | 2001 | 201 | 0.050 |
Why?
|
| Camurati-Engelmann Syndrome | 1 | 2004 | 1 | 0.050 |
Why?
|
| Jaw Abnormalities | 1 | 2004 | 2 | 0.050 |
Why?
|
| Decision Making | 1 | 2010 | 686 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 106 | 0.050 |
Why?
|
| Area Under Curve | 1 | 2005 | 340 | 0.050 |
Why?
|
| Chi-Square Distribution | 1 | 2005 | 360 | 0.050 |
Why?
|
| Peptides | 1 | 2026 | 669 | 0.050 |
Why?
|
| Minerals | 1 | 2022 | 21 | 0.050 |
Why?
|
| Quality Assurance, Health Care | 1 | 2004 | 228 | 0.050 |
Why?
|
| Mutation, Missense | 1 | 2004 | 302 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2009 | 1646 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2026 | 1950 | 0.050 |
Why?
|
| Observer Variation | 1 | 2003 | 579 | 0.040 |
Why?
|
| Reference Values | 2 | 2016 | 612 | 0.040 |
Why?
|
| Creatinine | 1 | 2022 | 313 | 0.040 |
Why?
|
| Delayed-Action Preparations | 1 | 2022 | 126 | 0.040 |
Why?
|
| Prodrugs | 1 | 2022 | 53 | 0.040 |
Why?
|
| Placebos | 1 | 2022 | 209 | 0.040 |
Why?
|
| Observational Studies as Topic | 1 | 2021 | 63 | 0.040 |
Why?
|
| Estrogen Receptor Modulators | 1 | 2001 | 10 | 0.040 |
Why?
|
| Calcitonin | 1 | 2001 | 41 | 0.040 |
Why?
|
| Young Adult | 2 | 2013 | 7511 | 0.040 |
Why?
|
| Estrogen Replacement Therapy | 1 | 2001 | 52 | 0.040 |
Why?
|
| Diphosphonates | 1 | 2001 | 36 | 0.040 |
Why?
|
| Calcifediol | 1 | 2020 | 23 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2022 | 839 | 0.040 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 79 | 0.040 |
Why?
|
| Forecasting | 1 | 2001 | 295 | 0.040 |
Why?
|
| Biomarkers | 1 | 2026 | 2022 | 0.040 |
Why?
|
| Hypercalcemia | 1 | 2017 | 60 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2004 | 1285 | 0.030 |
Why?
|
| Betacoronavirus | 1 | 2020 | 287 | 0.030 |
Why?
|
| Europe | 1 | 2017 | 356 | 0.030 |
Why?
|
| Symptom Assessment | 1 | 2016 | 78 | 0.030 |
Why?
|
| Animals | 4 | 2009 | 28902 | 0.030 |
Why?
|
| Calcium Citrate | 1 | 2013 | 2 | 0.030 |
Why?
|
| Spasm | 1 | 2013 | 17 | 0.030 |
Why?
|
| Hand Strength | 1 | 2013 | 60 | 0.020 |
Why?
|
| Back Pain | 1 | 2013 | 76 | 0.020 |
Why?
|
| Injections, Subcutaneous | 1 | 2013 | 141 | 0.020 |
Why?
|
| Headache | 1 | 2013 | 80 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2021 | 4825 | 0.020 |
Why?
|
| Adolescent | 3 | 2013 | 10097 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2013 | 764 | 0.020 |
Why?
|
| Models, Statistical | 1 | 2014 | 601 | 0.020 |
Why?
|
| Smoking | 1 | 2013 | 674 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 1 | 2009 | 24 | 0.020 |
Why?
|
| PPAR gamma | 1 | 2009 | 80 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2009 | 256 | 0.020 |
Why?
|
| Hematocrit | 1 | 1988 | 68 | 0.020 |
Why?
|
| Urea | 1 | 1988 | 54 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1988 | 44 | 0.020 |
Why?
|
| Luteinizing Hormone | 1 | 1988 | 146 | 0.020 |
Why?
|
| Osmolar Concentration | 1 | 1988 | 166 | 0.020 |
Why?
|
| Stem Cell Transplantation | 1 | 2009 | 194 | 0.020 |
Why?
|
| Blood Proteins | 1 | 1988 | 147 | 0.020 |
Why?
|
| Time Factors | 1 | 2016 | 5576 | 0.020 |
Why?
|
| Progesterone | 1 | 1988 | 126 | 0.020 |
Why?
|
| Cell Lineage | 1 | 2009 | 332 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2009 | 830 | 0.020 |
Why?
|
| Inappropriate ADH Syndrome | 1 | 1987 | 5 | 0.020 |
Why?
|
| Nutritional Physiological Phenomena | 1 | 1987 | 27 | 0.020 |
Why?
|
| Hyponatremia | 1 | 1987 | 31 | 0.020 |
Why?
|
| Sodium | 1 | 1988 | 330 | 0.020 |
Why?
|
| Body Weight | 1 | 1988 | 455 | 0.020 |
Why?
|
| Sodium Chloride | 1 | 1987 | 93 | 0.020 |
Why?
|
| Child | 2 | 2008 | 7699 | 0.010 |
Why?
|
| Postoperative Complications | 1 | 2016 | 2680 | 0.010 |
Why?
|
| Lod Score | 1 | 2004 | 152 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 111 | 0.010 |
Why?
|
| CHO Cells | 1 | 2004 | 188 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2009 | 2207 | 0.010 |
Why?
|
| Blood Pressure | 1 | 1988 | 910 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2004 | 290 | 0.010 |
Why?
|
| Radiometry | 1 | 2004 | 64 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2004 | 403 | 0.010 |
Why?
|
| Cricetinae | 1 | 2004 | 533 | 0.010 |
Why?
|
| Cloning, Molecular | 1 | 2004 | 581 | 0.010 |
Why?
|
| Genetic Linkage | 1 | 2004 | 613 | 0.010 |
Why?
|
| Transfection | 1 | 2004 | 883 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2004 | 257 | 0.010 |
Why?
|
| Mice | 2 | 2009 | 12697 | 0.010 |
Why?
|
| Pedigree | 1 | 2004 | 980 | 0.010 |
Why?
|
| Chromosome Mapping | 1 | 2004 | 1061 | 0.010 |
Why?
|
| Infant | 1 | 1988 | 3332 | 0.010 |
Why?
|
| Amino Acid Sequence | 1 | 2004 | 2005 | 0.010 |
Why?
|
| Child, Preschool | 1 | 1988 | 4006 | 0.010 |
Why?
|
| Molecular Sequence Data | 1 | 2004 | 2896 | 0.010 |
Why?
|